ESOMEPRAZOLE MAGNESIUM DIHYDRATE

ESOMEPRAZOLE MAGNESIUM DIHYDRATE was reported 14811 times

These side effects are most commonly reported by patients taking ESOMEPRAZOLE MAGNESIUM DIHYDRATE:

# Side effect Count
0 DRUG INEFFECTIVE 1481
1 NAUSEA 1386
2 HEADACHE 1250
3 FATIGUE 1105
4 DIARRHOEA 1103
5 OFF LABEL USE 1038
6 DYSPNOEA 1028
7 PAIN 990
8 CHRONIC KIDNEY DISEASE 862
9 ARTHRALGIA 827
10 MALAISE 780
11 ACUTE KIDNEY INJURY 749
12 VOMITING 694
13 COUGH 662
14 PNEUMONIA 635
15 PYREXIA 625
16 FALL 615
17 DIZZINESS 601
18 ANXIETY 590
19 RASH 584
20 ASTHENIA 581
21 PRURITUS 547
22 HYPERTENSION 539
23 ABDOMINAL PAIN UPPER 514
24 WEIGHT DECREASED 509
25 GASTROOESOPHAGEAL REFLUX DISEASE 501
26 HYPERHIDROSIS 485
27 BACK PAIN 467
28 CONDITION AGGRAVATED 452
29 MUSCULAR WEAKNESS 441
30 PRODUCT USE IN UNAPPROVED INDICATION 434
31 PAIN IN EXTREMITY 418
32 HYPERSENSITIVITY 415
33 ABDOMINAL DISCOMFORT 404
34 RHEUMATOID ARTHRITIS 397
35 ARTHRITIS 394
36 CHEST PAIN 385
37 ABDOMINAL PAIN 384
38 RENAL FAILURE 377
39 CONFUSIONAL STATE 376
40 NASOPHARYNGITIS 367
41 ASTHMA 366
42 PALPITATIONS 355
43 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 355
44 SINUSITIS 354
45 DRUG HYPERSENSITIVITY 351
46 DRUG INTERACTION 350
47 INSOMNIA 350
48 DYSPHAGIA 330
49 FEELING ABNORMAL 330
50 DEATH 325
51 NEPHROLITHIASIS 325
52 DRUG INTOLERANCE 315
53 CEREBROVASCULAR ACCIDENT 299
54 PRODUCT DOSE OMISSION ISSUE 298
55 DEPRESSION 296
56 DEHYDRATION 295
57 COVID-19 293
58 WHEEZING 289
59 HYPOTENSION 287
60 INFECTION 284
61 PERIPHERAL SWELLING 284
62 GASTROINTESTINAL DISORDER 283
63 BLOOD PRESSURE INCREASED 282
64 ANAEMIA 279
65 FIBROMYALGIA 276
66 NIGHTMARE 273
67 ANGIOEDEMA 260
68 SLEEP APNOEA SYNDROME 259
69 JOINT SWELLING 258
70 MUSCULOSKELETAL STIFFNESS 256
71 BLOOD GLUCOSE INCREASED 254
72 HYPOTHYROIDISM 252
73 ALOPECIA 251
74 URINARY TRACT INFECTION 251
75 MYALGIA 246
76 WEIGHT INCREASED 246
77 BURNING SENSATION 245
78 PRODUCT USE ISSUE 245
79 CARDIAC DISORDER 244
80 DECREASED APPETITE 244
81 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 243
82 SEDATION 240
83 ERYTHEMA 237
84 INFLUENZA 233
85 INTENTIONAL PRODUCT USE ISSUE 233
86 CONSTIPATION 231
87 INCORRECT DOSE ADMINISTERED 230
88 RENAL DISORDER 230
89 PSORIASIS 228
90 RENAL INJURY 222
91 BLOOD TEST ABNORMAL 219
92 CHEST DISCOMFORT 217
93 HAEMOGLOBIN DECREASED 216
94 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 216
95 OEDEMA PERIPHERAL 216
96 RHINORRHOEA 214
97 ATRIAL FIBRILLATION 212
98 HYPOAESTHESIA 212
99 HEART RATE INCREASED 211
100 NEUROPATHY PERIPHERAL 209
101 MIGRAINE 208
102 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 204
103 COORDINATION ABNORMAL 203
104 DYSPEPSIA 201
105 MEMORY IMPAIRMENT 201
106 CATARACT 200
107 END STAGE RENAL DISEASE 199
108 RESPIRATORY TRACT CONGESTION 198
109 C-REACTIVE PROTEIN INCREASED 195
110 DYSPHONIA 192
111 VISUAL IMPAIRMENT 192
112 INJECTION SITE PAIN 190
113 HEMIPLEGIA 189
114 RHINITIS ALLERGIC 189
115 URTICARIA 189
116 CARPAL TUNNEL SYNDROME 188
117 MYOCARDIAL INFARCTION 188
118 SOMNOLENCE 188
119 SWELLING FACE 188
120 PARAESTHESIA 183
121 SWELLING 183
122 DRY SKIN 182
123 NASAL CONGESTION 181
124 APHASIA 179
125 MUSCLE SPASMS 177
126 TACHYCARDIA 177
127 DYSARTHRIA 176
128 SENSITISATION 176
129 HALLUCINATION 175
130 POLYCYSTIC OVARIES 174
131 SWOLLEN TONGUE 174
132 HOSPITALISATION 173
133 SKIN EXFOLIATION 173
134 BRONCHITIS 172
135 CARDIAC FAILURE CONGESTIVE 170
136 COGNITIVE DISORDER 169
137 BLOOD CREATININE INCREASED 166
138 CYSTITIS 166
139 EATING DISORDER 166
140 INFUSION RELATED REACTION 165
141 TINNITUS 165
142 DRY MOUTH 164
143 HEMIPARESIS 164
144 INFLUENZA LIKE ILLNESS 164
145 RENAL IMPAIRMENT 164
146 GENERAL PHYSICAL HEALTH DETERIORATION 163
147 MUSCLE SPASTICITY 162
148 MOTOR DYSFUNCTION 161
149 AFFECT LABILITY 160
150 SENSORY LOSS 159
151 PERSONALITY DISORDER 158
152 WHITE BLOOD CELL COUNT DECREASED 158
153 OXYGEN SATURATION DECREASED 154
154 CONTRAINDICATED PRODUCT ADMINISTERED 153
155 SYNCOPE 153
156 CAROTID ARTERY THROMBOSIS 152
157 AMNESIA 151
158 GAIT DISTURBANCE 151
159 INTERSTITIAL LUNG DISEASE 151
160 NEUROLOGIC NEGLECT SYNDROME 151
161 SINUS CONGESTION 149
162 ADJUSTMENT DISORDER 147
163 OVERDOSE 147
164 SNEEZING 147
165 ALANINE AMINOTRANSFERASE INCREASED 145
166 CARDIAC FAILURE 145
167 CHILLS 144
168 TREATMENT FAILURE 144
169 ANGINA PECTORIS 141
170 SEPSIS 141
171 VISION BLURRED 141
172 LOSS OF CONSCIOUSNESS 140
173 OROPHARYNGEAL PAIN 140
174 THERAPEUTIC PRODUCT EFFECT DECREASED 140
175 METABOLIC ACIDOSIS 139
176 THROMBOCYTOPENIA 138
177 TREMOR 138
178 ULCER 138
179 UPPER RESPIRATORY TRACT INFECTION 138
180 EJECTION FRACTION 137
181 LUNG DISORDER 137
182 SINUS DISORDER 137
183 DRY EYE 136
184 HEPATIC ENZYME INCREASED 136
185 RHEUMATOID NODULE 136
186 HYPONATRAEMIA 133
187 INTENTIONAL PRODUCT MISUSE 133
188 DIPLOPIA 132
189 SEROTONIN SYNDROME 130
190 TUBULOINTERSTITIAL NEPHRITIS 129
191 PLATELET COUNT DECREASED 128
192 SKIN HAEMORRHAGE 127
193 VENTRICULAR TACHYCARDIA 127
194 MUSCULOSKELETAL PAIN 126
195 RESPIRATORY FAILURE 126
196 FLUSHING 125
197 PULMONARY EMBOLISM 125
198 SUICIDE ATTEMPT 125
199 BLINDNESS 124
200 PERICARDITIS 124
201 RASH PRURITIC 124
202 TRANSIENT ISCHAEMIC ATTACK 124
203 EYE IRRITATION 123
204 PLEURAL EFFUSION 123
205 PULMONARY OEDEMA 123
206 DISTURBANCE IN ATTENTION 120
207 INFLAMMATION 119
208 ABDOMINAL DISTENSION 118
209 INJECTION SITE REACTION 118
210 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 117
211 ADVERSE EVENT 116
212 ILLNESS 115
213 INTENTIONAL OVERDOSE 114
214 EYE PAIN 113
215 RED BLOOD CELL SEDIMENTATION RATE INCREASED 113
216 BALANCE DISORDER 112
217 DIABETES MELLITUS 112
218 PERICARDIAL EFFUSION 112
219 THROAT IRRITATION 110
220 VASCULITIS 109
221 IMPAIRED HEALING 108
222 LIP SWELLING 108
223 NEUTROPENIA 108
224 KIDNEY INFECTION 107
225 NEPHROPATHY 107
226 THERAPEUTIC RESPONSE DECREASED 107
227 HYPOKALAEMIA 106
228 LIVER DISORDER 106
229 EYE PRURITUS 105
230 HERPES ZOSTER 105
231 RED BLOOD CELL COUNT DECREASED 105
232 RENAL FAILURE ACUTE 105
233 ANAPHYLACTIC REACTION 104
234 ARTERIAL OCCLUSIVE DISEASE 104
235 STRESS 104
236 GANGRENE 103
237 MUSCLE TWITCHING 103
238 PRODUCTIVE COUGH 103
239 SKIN ULCER 102
240 MAJOR DEPRESSION 101
241 MALNUTRITION 101
242 ASPARTATE AMINOTRANSFERASE INCREASED 100
243 THROMBOSIS 100
244 FACIAL PAIN 99
245 SEPTIC SHOCK 99
246 BLOOD PRESSURE DECREASED 98
247 SUBARACHNOID HAEMORRHAGE 97
248 CAROTID ARTERY OCCLUSION 96
249 CONTUSION 96
250 PAIN OF SKIN 96
251 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 96
252 FULL BLOOD COUNT ABNORMAL 95
253 OSTEOARTHRITIS 95
254 PHYSICAL DECONDITIONING 95
255 ATRIAL TACHYCARDIA 93
256 LOWER RESPIRATORY TRACT INFECTION 93
257 ANOSMIA 92
258 CARDIOSPASM 92
259 SLEEP TERROR 92
260 OSTEOPOROSIS 91
261 PRURITUS GENITAL 91
262 TENSION HEADACHE 91
263 STOMATITIS 90
264 PALMOPLANTAR KERATODERMA 89
265 TOXICITY TO VARIOUS AGENTS 88
266 ARTHROPATHY 87
267 TOOTH DISORDER 87
268 WHITE BLOOD CELL COUNT INCREASED 87
269 DISCOMFORT 86
270 DYSGEUSIA 86
271 NECK PAIN 86
272 SLEEP DISORDER 86
273 DEEP VEIN THROMBOSIS 85
274 FOOT DEFORMITY 84
275 PULMONARY CONGESTION 84
276 THYROID DISORDER 84
277 INCORRECT PRODUCT ADMINISTRATION DURATION 83
278 VERTIGO 83
279 TOOTH INFECTION 82
280 BLOOD PRESSURE FLUCTUATION 81
281 FEBRILE NEUTROPENIA 81
282 HOT FLUSH 81
283 RHABDOMYOLYSIS 81
284 ADVERSE DRUG REACTION 80
285 BLOOD PRESSURE DIASTOLIC DECREASED 80
286 BLOOD UREA INCREASED 80
287 TYPE 2 DIABETES MELLITUS 80
288 DEPRESSED MOOD 79
289 RESPIRATORY DISTRESS 79
290 TENDERNESS 79
291 DRUG-INDUCED LIVER INJURY 78
292 DYSPNOEA EXERTIONAL 78
293 NERVE INJURY 78
294 BLOOD ALKALINE PHOSPHATASE INCREASED 77
295 EYE HAEMORRHAGE 77
296 IMPAIRED WORK ABILITY 77
297 FEELING HOT 76
298 PANCYTOPENIA 76
299 RASH MACULO-PAPULAR 76
300 SYNOVIAL CYST 75
301 THERAPY NON-RESPONDER 75
302 HYPOMAGNESAEMIA 73
303 DRUG ERUPTION 72
304 DYSURIA 72
305 FLATULENCE 72
306 BREATH SOUNDS ABNORMAL 71
307 CARDIAC ARREST 71
308 ECZEMA 71
309 GASTROINTESTINAL HAEMORRHAGE 71
310 LEUKOPENIA 71
311 MOBILITY DECREASED 71
312 BRADYCARDIA 70
313 EJECTION FRACTION ABNORMAL 70
314 OBSTRUCTIVE AIRWAYS DISORDER 70
315 HYPERKALAEMIA 69
316 MULTI-ORGAN DISORDER 69
317 RASH PAPULAR 69
318 BLOOD PRESSURE SYSTOLIC INCREASED 68
319 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 68
320 OEDEMA 68
321 FUNGAL INFECTION 67
322 HEART RATE DECREASED 67
323 INJECTION SITE ERYTHEMA 67
324 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 67
325 ADRENAL INSUFFICIENCY 66
326 BLOOD GLUCOSE DECREASED 66
327 HUNGER 66
328 OCULAR HYPERAEMIA 66
329 PULMONARY FIBROSIS 65
330 AGITATION 63
331 BLOOD CHOLESTEROL INCREASED 63
332 HYPOXIA 63
333 PSORIATIC ARTHROPATHY 63
334 RECTAL HAEMORRHAGE 63
335 RESPIRATORY DISORDER 63
336 SURGERY 63
337 EPISTAXIS 62
338 JAUNDICE 62
339 HAEMATOCHEZIA 61
340 OBSTRUCTIVE SLEEP APNOEA SYNDROME 61
341 PRESCRIBED UNDERDOSE 61
342 TENOSYNOVITIS 61
343 COMA 60
344 DISEASE RECURRENCE 60
345 HEPATIC FUNCTION ABNORMAL 60
346 JOINT STIFFNESS 60
347 TEMPERATURE INTOLERANCE 60
348 ASCITES 59
349 BURSITIS 59
350 CORONARY ARTERY DISEASE 59
351 FLUID RETENTION 59
352 HAEMORRHAGE 59
353 HEPATITIS 59
354 NEOPLASM MALIGNANT 59
355 GASTRITIS 58
356 PHOTOPHOBIA 58
357 SYNOVITIS 58
358 CELLULITIS 57
359 CONJUNCTIVITIS 57
360 DRUG LEVEL INCREASED 57
361 NEUTROPHIL COUNT DECREASED 57
362 NEUTROPHIL COUNT INCREASED 57
363 RHINITIS 57
364 CHOLESTASIS 56
365 IMMUNISATION 56
366 MULTIPLE SCLEROSIS 56
367 SYSTEMIC LUPUS ERYTHEMATOSUS 56
368 ACUTE MYOCARDIAL INFARCTION 55
369 ATELECTASIS 55
370 BLOOD IRON DECREASED 55
371 DELIRIUM 55
372 MALIGNANT NEOPLASM PROGRESSION 55
373 POST-TRAUMATIC STRESS DISORDER 55
374 UNRESPONSIVE TO STIMULI 55
375 COLITIS ULCERATIVE 54
376 CROHN^S DISEASE 54
377 DISEASE PROGRESSION 54
378 HEPATIC STEATOSIS 54
379 JOINT RANGE OF MOTION DECREASED 54
380 VITAMIN D DEFICIENCY 54
381 GASTRIC DISORDER 53
382 HYPERLIPIDAEMIA 53
383 MATERNAL EXPOSURE DURING PREGNANCY 53
384 ROAD TRAFFIC ACCIDENT 53
385 STAPHYLOCOCCAL INFECTION 53
386 SUICIDAL IDEATION 53
387 ELECTROCARDIOGRAM QT PROLONGED 52
388 HIATUS HERNIA 52
389 HYPOCALCAEMIA 52
390 MULTIPLE ORGAN DYSFUNCTION SYNDROME 52
391 SEASONAL ALLERGY 52
392 SINUS TACHYCARDIA 52
393 DEMYELINATION 51
394 HYPOGLYCAEMIA 51
395 INTESTINAL OBSTRUCTION 51
396 PANCREATITIS 51
397 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 51
398 PROTEINURIA 51
399 BASAL CELL CARCINOMA 50
400 BONE DENSITY DECREASED 50
401 DIALYSIS 50
402 GLYCOSYLATED HAEMOGLOBIN INCREASED 50
403 LACTIC ACIDOSIS 50
404 RASH ERYTHEMATOUS 50
405 GAMMA-GLUTAMYLTRANSFERASE INCREASED 49
406 INTERNATIONAL NORMALISED RATIO INCREASED 49
407 INTERVERTEBRAL DISCITIS 49
408 JOINT EFFUSION 49
409 LETHARGY 49
410 MEDICATION ERROR 49
411 MIOSIS 49
412 NEPHRECTOMY 49
413 SKIN DISCOLOURATION 49
414 DISORIENTATION 48
415 EMOTIONAL DISTRESS 48
416 GASTRIC ULCER 48
417 HEPATIC FAILURE 48
418 PANCREATITIS ACUTE 48
419 URINARY INCONTINENCE 48
420 ACUTE RESPIRATORY FAILURE 47
421 LIMB DISCOMFORT 47
422 SPINAL DISORDER 47
423 CHOLECYSTITIS ACUTE 46
424 CREPITATIONS 46
425 ELECTRIC SHOCK 46
426 HAEMOPTYSIS 46
427 POLLAKIURIA 46
428 BACTERIAL INFECTION 45
429 BONE PAIN 45
430 EOSINOPHILIA 45
431 HAEMATURIA 45
432 INJECTION SITE PRURITUS 45
433 LIVER FUNCTION TEST ABNORMAL 45
434 LYMPHOCYTE COUNT DECREASED 45
435 SEIZURE 45
436 AGRANULOCYTOSIS 44
437 BREAST CANCER 44
438 CONVULSION 44
439 EAR INFECTION 44
440 FEELING JITTERY 44
441 PRODUCT SUBSTITUTION ISSUE 44
442 SKIN LESION 44
443 VITAMIN B12 DEFICIENCY 44
444 ANKLE FRACTURE 43
445 BLOOD URIC ACID INCREASED 43
446 DIVERTICULITIS 43
447 DRUG DOSE OMISSION 43
448 ILL-DEFINED DISORDER 43
449 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 43
450 ISCHAEMIC STROKE 43
451 LYMPHADENOPATHY 43
452 MUSCULOSKELETAL DISCOMFORT 43
453 ORAL PAIN 43
454 BLISTER 42
455 COLITIS 42
456 HEPATIC CYTOLYSIS 42
457 PANNICULITIS 42
458 PNEUMONIA ASPIRATION 42
459 UNDERDOSE 42
460 BONE MARROW FAILURE 41
461 INTENTIONAL DOSE OMISSION 41
462 LARGE INTESTINE POLYP 41
463 PAIN IN JAW 41
464 RASH MACULAR 41
465 SKIN DISORDER 41
466 WOUND 41
467 ACCIDENTAL OVERDOSE 40
468 BLOOD PRESSURE SYSTOLIC DECREASED 40
469 CHOLELITHIASIS 40
470 DACTYLITIS 40
471 FLANK PAIN 40
472 GLOMERULAR FILTRATION RATE INCREASED 40
473 HAEMATOMA 40
474 HEAD INJURY 40
475 HEART RATE IRREGULAR 40
476 HYPERCALCAEMIA 40
477 INJECTION SITE EXTRAVASATION 40
478 NEPHROGENIC ANAEMIA 40
479 NIGHT SWEATS 40
480 PRODUCT USED FOR UNKNOWN INDICATION 40
481 PULMONARY TOXICITY 40
482 RENAL CYST 40
483 ARRHYTHMIA 39
484 DRUG TOLERANCE DECREASED 39
485 GLOSSODYNIA 39
486 MONOCYTE COUNT INCREASED 39
487 PANIC ATTACK 39
488 RHEUMATOID FACTOR POSITIVE 39
489 BLOOD PARATHYROID HORMONE DECREASED 38
490 GRANULOCYTE COUNT INCREASED 38
491 JOINT INJURY 38
492 JOINT NOISE 38
493 MOUTH ULCERATION 38
494 NO ADVERSE EVENT 38
495 NOCTURIA 38
496 NODULE 38
497 POST CHOLECYSTECTOMY SYNDROME 38
498 TENOSYNOVITIS STENOSANS 38
499 UNEVALUABLE EVENT 38
500 VITAMIN B12 INCREASED 38
501 BLOOD BILIRUBIN INCREASED 37
502 BLOOD CREATINE PHOSPHOKINASE INCREASED 37
503 BLOOD IMMUNOGLOBULIN A INCREASED 37
504 HEPATIC CIRRHOSIS 37
505 HEPATOTOXICITY 37
506 INJECTION SITE BRUISING 37
507 INJECTION SITE SWELLING 37
508 MITRAL VALVE INCOMPETENCE 37
509 POLYP 37
510 RENAL TUBULAR NECROSIS 37
511 RHEUMATOID FACTOR INCREASED 37
512 SCIATICA 37
513 SKIN NECROSIS 37
514 SPEECH DISORDER 37
515 THROAT CLEARING 37
516 VIRAL INFECTION 37
517 BLOOD POTASSIUM DECREASED 36
518 EPILEPSY 36
519 EYELID OEDEMA 36
520 GRANULOMA SKIN 36
521 INTERVERTEBRAL DISC PROTRUSION 36
522 MOUTH HAEMORRHAGE 36
523 NEOPLASM PROGRESSION 36
524 ORAL HERPES 36
525 PLEURITIC PAIN 36
526 PULMONARY HYPERTENSION 36
527 SKIN BURNING SENSATION 36
528 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 36
529 TREATMENT NONCOMPLIANCE 36
530 URINARY RETENTION 36
531 AFFECTIVE DISORDER 35
532 AREFLEXIA 35
533 ASPARTATE AMINOTRANSFERASE ABNORMAL 35
534 BLOOD SODIUM DECREASED 35
535 CUSHINGOID 35
536 DEAFNESS 35
537 HAEMATEMESIS 35
538 HAEMATOCRIT DECREASED 35
539 PRODUCT DOSE OMISSION 35
540 RESPIRATORY TRACT INFECTION 35
541 RETCHING 35
542 THERAPEUTIC RESPONSE SHORTENED 35
543 WHITE BLOOD CELLS URINE POSITIVE 35
544 ACUTE RESPIRATORY DISTRESS SYNDROME 34
545 ANAL ABSCESS 34
546 DEPRESSED LEVEL OF CONSCIOUSNESS 34
547 MIDDLE INSOMNIA 34
548 MUSCULOSKELETAL CHEST PAIN 34
549 PNEUMONIA HAEMOPHILUS 34
550 PNEUMONITIS 34
551 SCLERITIS 34
552 TENDON RUPTURE 34
553 BODY TEMPERATURE DECREASED 33
554 BRONCHIECTASIS 33
555 CANDIDA INFECTION 33
556 CARDIOMEGALY 33
557 EPIGASTRIC DISCOMFORT 33
558 ERUCTATION 33
559 GAIT INABILITY 33
560 HIP FRACTURE 33
561 HYPERGLYCAEMIA 33
562 IMPAIRED QUALITY OF LIFE 33
563 NERVOUSNESS 33
564 PRODUCT QUALITY ISSUE 33
565 RALES 33
566 THERAPY INTERRUPTED 33
567 TRICUSPID VALVE INCOMPETENCE 33
568 ALTERED STATE OF CONSCIOUSNESS 32
569 DEFORMITY 32
570 DERMATITIS ATOPIC 32
571 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 32
572 FOETAL EXPOSURE DURING PREGNANCY 32
573 HYPOPHAGIA 32
574 RESTLESS LEGS SYNDROME 32
575 RIB FRACTURE 32
576 ALLERGY TO CHEMICALS 31
577 COMPLETED SUICIDE 31
578 DIABETIC NEPHROPATHY 31
579 DIASTOLIC DYSFUNCTION 31
580 DRUG EFFECT LESS THAN EXPECTED 31
581 EXPOSURE DURING PREGNANCY 31
582 HAND DEFORMITY 31
583 LYMPHOMA 31
584 NASAL DISCHARGE DISCOLOURATION 31
585 NIPPLE SWELLING 31
586 PRE-EXISTING CONDITION IMPROVED 31
587 SHOCK 31
588 BRONCHIAL DISORDER 30
589 CARDIAC MURMUR 30
590 CEREBRAL INFARCTION 30
591 EAR PAIN 30
592 FACIAL PARALYSIS 30
593 FREQUENT BOWEL MOVEMENTS 30
594 HALLUCINATION, VISUAL 30
595 HEPATOCELLULAR INJURY 30
596 MELAENA 30
597 NIPPLE PAIN 30
598 PHLEBITIS 30
599 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 30
600 STEVENS-JOHNSON SYNDROME 30
601 THROAT TIGHTNESS 30
602 TOXIC EPIDERMAL NECROLYSIS 30
603 ANHEDONIA 29
604 ANTINUCLEAR ANTIBODY POSITIVE 29
605 BODY TEMPERATURE INCREASED 29
606 BUNION OPERATION 29
607 CARDIO-RESPIRATORY ARREST 29
608 COVID-19 PNEUMONIA 29
609 DEMENTIA 29
610 DEVICE ISSUE 29
611 DYSLIPIDAEMIA 29
612 FEMUR FRACTURE 29
613 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 29
614 LEFT VENTRICULAR HYPERTROPHY 29
615 LIMB INJURY 29
616 MAST CELL ACTIVATION SYNDROME 29
617 NEEDLE ISSUE 29
618 OSTEONECROSIS 29
619 PLATELET COUNT INCREASED 29
620 TONGUE BITING 29
621 BRAIN SCAN ABNORMAL 28
622 CHRONIC SINUSITIS 28
623 DRUG DELIVERY SYSTEM MALFUNCTION 28
624 FOLLICULITIS 28
625 FOOT OPERATION 28
626 HERNIA 28
627 HUMAN RHINOVIRUS TEST POSITIVE 28
628 INFUSION SITE ERYTHEMA 28
629 INJECTION SITE HAEMORRHAGE 28
630 INJECTION SITE IRRITATION 28
631 MOVEMENT DISORDER 28
632 PRESYNCOPE 28
633 SPINAL OSTEOARTHRITIS 28
634 SUPRAVENTRICULAR TACHYCARDIA 28
635 TOXIC SKIN ERUPTION 28
636 VIRAL TEST POSITIVE 28
637 BLOOD PRESSURE ABNORMAL 27
638 BRONCHIAL HAEMORRHAGE 27
639 BRONCHIAL NEOPLASM 27
640 CEREBRAL ARTERY THROMBOSIS 27
641 EYE SWELLING 27
642 GRANULOMA 27
643 INJECTION SITE MASS 27
644 IRON DEFICIENCY ANAEMIA 27
645 LIVER INJURY 27
646 MUCOSAL INFLAMMATION 27
647 NASAL TURBINATE HYPERTROPHY 27
648 NEURALGIA 27
649 QUALITY OF LIFE DECREASED 27
650 RESTLESSNESS 27
651 RHONCHI 27
652 VENTRICULAR HYPOKINESIA 27
653 WRONG TECHNIQUE IN DRUG USAGE PROCESS 27
654 ACCIDENT 26
655 ANAPHYLACTIC SHOCK 26
656 CYST 26
657 EJECTION FRACTION DECREASED 26
658 ENDOMETRIAL ABLATION 26
659 FEEDING DISORDER 26
660 GASTRIC CANCER 26
661 GASTROINTESTINAL MOTILITY DISORDER 26
662 GENERALISED OEDEMA 26
663 INSURANCE ISSUE 26
664 MENTAL DISORDER 26
665 PRODUCT ADMINISTRATION INTERRUPTED 26
666 UPPER-AIRWAY COUGH SYNDROME 26
667 ANAEMIA MACROCYTIC 25
668 CAROTID ARTERIOSCLEROSIS 25
669 CHOLANGITIS 25
670 CORONARY ARTERY OCCLUSION 25
671 ENCEPHALOPATHY 25
672 FOOT FRACTURE 25
673 GASTROENTERITIS VIRAL 25
674 INFUSION SITE PAIN 25
675 INJECTION SITE WARMTH 25
676 IRRITABLE BOWEL SYNDROME 25
677 LACRIMATION INCREASED 25
678 OSTEOPENIA 25
679 SKIN LACERATION 25
680 SKIN PLAQUE 25
681 SYNOVIAL FLUID ANALYSIS 25
682 WOUND INFECTION 25
683 ABNORMAL DREAMS 24
684 BLOOD LACTATE DEHYDROGENASE INCREASED 24
685 CAROTID ARTERY STENOSIS 24
686 CYTOLYTIC HEPATITIS 24
687 DECREASED IMMUNE RESPONSIVENESS 24
688 DRUG ABUSE 24
689 ELECTROLYTE IMBALANCE 24
690 ENCEPHALITIS 24
691 ESSENTIAL HYPERTENSION 24
692 FAECES DISCOLOURED 24
693 GASTRIC POLYPS 24
694 GASTROENTERITIS 24
695 HELICOBACTER INFECTION 24
696 HYPERSOMNIA 24
697 HYPERTENSIVE NEPHROPATHY 24
698 HYPOACUSIS 24
699 HYPOALBUMINAEMIA 24
700 INJURY 24
701 MYELOSUPPRESSION 24
702 POOR QUALITY SLEEP 24
703 SPINAL FRACTURE 24
704 TASTE DISORDER 24
705 TRANSAMINASES INCREASED 24
706 VARICOSE VEIN 24
707 ABDOMINAL PAIN LOWER 23
708 CLOSTRIDIUM DIFFICILE INFECTION 23
709 DERMATITIS BULLOUS 23
710 DISABILITY 23
711 ECONOMIC PROBLEM 23
712 EMPHYSEMA 23
713 EYE INFECTION 23
714 FACE OEDEMA 23
715 FEAR 23
716 FOETAL GROWTH RESTRICTION 23
717 HEPATIC PAIN 23
718 HYPERTHERMIA 23
719 INTERVERTEBRAL DISC DEGENERATION 23
720 JOINT DISLOCATION 23
721 LOSS OF EMPLOYMENT 23
722 LUNG INFILTRATION 23
723 PHARYNGEAL SWELLING 23
724 SYNOVIAL DISORDER 23
725 DYSSTASIA 22
726 HYPERCHOLESTEROLAEMIA 22
727 LOCALISED INFECTION 22
728 MULTIPLE SCLEROSIS RELAPSE 22
729 MYOCLONUS 22
730 OBESITY 22
731 OVARIAN CYST 22
732 PHARYNGITIS 22
733 PULMONARY MASS 22
734 REBOUND ACID HYPERSECRETION 22
735 SKIN FISSURES 22
736 SUBDURAL HAEMATOMA 22
737 UPPER GASTROINTESTINAL HAEMORRHAGE 22
738 AGGRESSION 21
739 AORTIC VALVE INCOMPETENCE 21
740 APHTHOUS ULCER 21
741 BLOOD ALBUMIN DECREASED 21
742 BLOOD POTASSIUM INCREASED 21
743 BLOOD TRIGLYCERIDES INCREASED 21
744 BLOOD URINE PRESENT 21
745 CHOKING 21
746 DISSEMINATED INTRAVASCULAR COAGULATION 21
747 DRUG DEPENDENCE 21
748 EXPOSURE VIA SKIN CONTACT 21
749 GLAUCOMA 21
750 GOUT 21
751 INJECTION SITE INDURATION 21
752 LIVER FUNCTION TEST INCREASED 21
753 MENTAL STATUS CHANGES 21
754 MUSCLE CONTRACTIONS INVOLUNTARY 21
755 OESOPHAGITIS 21
756 PALLOR 21
757 POLYARTHRITIS 21
758 PRODUCT DOSE OMISSION IN ERROR 21
759 SENSITIVITY TO WEATHER CHANGE 21
760 THERAPEUTIC RESPONSE UNEXPECTED 21
761 VITAMIN D DECREASED 21
762 ANGIOPATHY 20
763 BACK DISORDER 20
764 BONE DISORDER 20
765 CHROMATURIA 20
766 CYTOKINE RELEASE SYNDROME 20
767 DERMATITIS 20
768 EOSINOPHIL COUNT INCREASED 20
769 GASTROINTESTINAL TOXICITY 20
770 GINGIVAL PAIN 20
771 HYPOPNOEA 20
772 ILEUS 20
773 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 20
774 LEUKOCYTOSIS 20
775 MULTIPLE ALLERGIES 20
776 MYOCARDIAL ISCHAEMIA 20
777 POST PROCEDURAL COMPLICATION 20
778 PRURITUS GENERALISED 20
779 SPUTUM DISCOLOURED 20
780 ACNE 19
781 ATTENTION DEFICIT HYPERACTIVITY DISORDER 19
782 BURNS SECOND DEGREE 19
783 CARDIAC DISCOMFORT 19
784 CHOLECYSTITIS 19
785 CYTOMEGALOVIRUS INFECTION 19
786 DERMATITIS CONTACT 19
787 DRUG EFFECT INCOMPLETE 19
788 DYSKINESIA 19
789 DYSPNOEA AT REST 19
790 HELICOBACTER GASTRITIS 19
791 HEPATITIS ACUTE 19
792 HEPATOJUGULAR REFLUX 19
793 LIPASE INCREASED 19
794 LUNG NEOPLASM MALIGNANT 19
795 POOR VENOUS ACCESS 19
796 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 19
797 PSYCHOTIC DISORDER 19
798 SOMNAMBULISM 19
799 SYSTOLIC DYSFUNCTION 19
800 THIRST 19
801 APHONIA 18
802 ATRIOVENTRICULAR BLOCK COMPLETE 18
803 BACTERAEMIA 18
804 BLOOD CALCIUM DECREASED 18
805 BLOOD PRESSURE DIASTOLIC ABNORMAL 18
806 BRONCHOSPASM 18
807 CATARRH 18
808 CEREBRAL HAEMORRHAGE 18
809 CHOLECYSTECTOMY 18
810 CONCUSSION 18
811 DELUSION 18
812 DIVERTICULUM 18
813 DRUG TOXICITY 18
814 ELECTROCARDIOGRAM Q WAVE ABNORMAL 18
815 EXTRA DOSE ADMINISTERED 18
816 EYE DISORDER 18
817 FOETAL ANAEMIA 18
818 FULL BLOOD COUNT DECREASED 18
819 GASTROINTESTINAL PAIN 18
820 HAEMOGLOBIN INCREASED 18
821 HAEMORRHOIDS 18
822 HEAD DISCOMFORT 18
823 HEPATOMEGALY 18
824 HYPERAESTHESIA 18
825 HYPERCHLORHYDRIA 18
826 HYPOPHOSPHATAEMIA 18
827 IMMUNE SYSTEM DISORDER 18
828 IMPAIRED GASTRIC EMPTYING 18
829 INFUSION SITE PRURITUS 18
830 INGROWING NAIL 18
831 INJECTION SITE RASH 18
832 IRRITABILITY 18
833 MOOD ALTERED 18
834 MULTI-ORGAN FAILURE 18
835 NASAL DRYNESS 18
836 OROPHARYNGEAL DISCOMFORT 18
837 PLASMA CELL MYELOMA 18
838 PLEURISY 18
839 POLYURIA 18
840 ATRIAL FLUTTER 17
841 BENIGN PROSTATIC HYPERPLASIA 17
842 BLOOD GLUCOSE ABNORMAL 17
843 BLOOD THYROID STIMULATING HORMONE INCREASED 17
844 BOWEL MOVEMENT IRREGULARITY 17
845 CROHN'S DISEASE 17
846 ERECTILE DYSFUNCTION 17
847 EXOSTOSIS 17
848 FEELING COLD 17
849 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 17
850 HEPATIC ENCEPHALOPATHY 17
851 INJECTION SITE HYPERSENSITIVITY 17
852 LUNG OPACITY 17
853 MICTURITION URGENCY 17
854 MUSCLE STRAIN 17
855 OCCULT BLOOD 17
856 ORAL CANDIDIASIS 17
857 PANCREATIC NEUROENDOCRINE TUMOUR 17
858 PAROSMIA 17
859 PNEUMOCYSTIS JIROVECII PNEUMONIA 17
860 PNEUMOTHORAX 17
861 PRODUCT AVAILABILITY ISSUE 17
862 PROTEIN URINE PRESENT 17
863 ROTATOR CUFF SYNDROME 17
864 UPPER LIMB FRACTURE 17
865 ABNORMAL BEHAVIOUR 16
866 ACCIDENTAL EXPOSURE TO PRODUCT 16
867 ACUTE HEPATIC FAILURE 16
868 ASPARTATE AMINOTRANSFERASE 16
869 BASEDOW^S DISEASE 16
870 BIPOLAR DISORDER 16
871 BLOOD PRESSURE SYSTOLIC ABNORMAL 16
872 BUNDLE BRANCH BLOCK LEFT 16
873 CARDIAC FAILURE CHRONIC 16
874 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 16
875 DEVICE MALFUNCTION 16
876 DUODENAL ULCER PERFORATION 16
877 FRACTURE 16
878 HAEMOLYSIS 16
879 INCONTINENCE 16
880 INCREASED APPETITE 16
881 IRON DEFICIENCY 16
882 MENISCUS INJURY 16
883 MUSCLE TIGHTNESS 16
884 NEPHRITIC SYNDROME 16
885 PEMPHIGUS 16
886 PERITONITIS 16
887 PHARYNGOLARYNGEAL PAIN 16
888 PNEUMONIA BACTERIAL 16
889 RHINALGIA 16
890 SMALL INTESTINAL OBSTRUCTION 16
891 VENTRICULAR EXTRASYSTOLES 16
892 C-REACTIVE PROTEIN ABNORMAL 15
893 CATHETER SITE PAIN 15
894 CYTOPENIA 15
895 ENTHESOPATHY 15
896 ESCHERICHIA INFECTION 15
897 FACET JOINT SYNDROME 15
898 GRAND MAL CONVULSION 15
899 HAEMORRHAGE FOETAL 15
900 HEPATITIS VIRAL 15
901 HYPERPARATHYROIDISM SECONDARY 15
902 HYPOAESTHESIA ORAL 15
903 HYSTERECTOMY 15
904 INCORRECT DRUG ADMINISTRATION DURATION 15
905 INITIAL INSOMNIA 15
906 INTESTINAL PERFORATION 15
907 JAW CLICKING 15
908 KNEE ARTHROPLASTY 15
909 LUNG INFECTION 15
910 MANIA 15
911 METASTASES TO LIVER 15
912 MOOD SWINGS 15
913 MYOPATHY 15
914 NERVE COMPRESSION 15
915 ORTHOSTATIC HYPOTENSION 15
916 PARAESTHESIA ORAL 15
917 PROCEDURAL PAIN 15
918 PSEUDOMONAL SEPSIS 15
919 PYELONEPHRITIS 15
920 SENSORY DISTURBANCE 15
921 SERUM FERRITIN INCREASED 15
922 THERAPY PARTIAL RESPONDER 15
923 TOXIC ENCEPHALOPATHY 15
924 ANOREXIA 14
925 BACK INJURY 14
926 BLOOD IMMUNOGLOBULIN E INCREASED 14
927 BRUXISM 14
928 CARDIAC TAMPONADE 14
929 CARDIOGENIC SHOCK 14
930 CRYING 14
931 DENTAL RESTORATION FAILURE 14
932 DIVERTICULUM INTESTINAL 14
933 DRUG EFFECT DECREASED 14
934 DRUG WITHDRAWAL SYNDROME 14
935 EYE DISCHARGE 14
936 GLOSSITIS 14
937 HAEMODYNAMIC INSTABILITY 14
938 HAEMOLYTIC ANAEMIA 14
939 HEPATOSPLENOMEGALY 14
940 HYPERNATRAEMIA 14
941 HYPERTHYROIDISM 14
942 IMMUNODEFICIENCY 14
943 INFUSION SITE HAEMORRHAGE 14
944 LEFT VENTRICULAR DYSFUNCTION 14
945 LEFT VENTRICULAR FAILURE 14
946 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 14
947 NERVOUS SYSTEM DISORDER 14
948 OCULAR DISCOMFORT 14
949 PAPULE 14
950 PELVIC FRACTURE 14
951 PELVIC PAIN 14
952 POLYNEUROPATHY 14
953 PRODUCT TASTE ABNORMAL 14
954 PSEUDOMONAS INFECTION 14
955 RENAL ATROPHY 14
956 RENAL FAILURE CHRONIC 14
957 RESPIRATORY RATE INCREASED 14
958 RHEUMATIC FEVER 14
959 SENSATION OF FOREIGN BODY 14
960 TACHYPNOEA 14
961 TOOTH EXTRACTION 14
962 TUMOUR LYSIS SYNDROME 14
963 URINE LEUKOCYTE ESTERASE POSITIVE 14
964 WEIGHT FLUCTUATION 14
965 ALCOHOL POISONING 13
966 ANGER 13
967 ANKYLOSING SPONDYLITIS 13
968 ARTERIOSCLEROSIS 13
969 BLOOD MAGNESIUM DECREASED 13
970 BODY HEIGHT DECREASED 13
971 BUNDLE BRANCH BLOCK RIGHT 13
972 CHOKING SENSATION 13
973 CIRCULATORY COLLAPSE 13
974 CORONARY ARTERY STENOSIS 13
975 DECREASED ACTIVITY 13
976 DEVICE OCCLUSION 13
977 DEVICE RELATED INFECTION 13
978 DIABETIC KETOACIDOSIS 13
979 GLOMERULAR FILTRATION RATE DECREASED 13
980 GRIP STRENGTH DECREASED 13
981 HAEMATOMA MUSCLE 13
982 HAEMODIALYSIS 13
983 HALLUCINATION, AUDITORY 13
984 HYDRONEPHROSIS 13
985 HYPERTRIGLYCERIDAEMIA 13
986 HYPERURICAEMIA 13
987 IMMUNOSUPPRESSION 13
988 IMPAIRED DRIVING ABILITY 13
989 INFUSION SITE SWELLING 13
990 INJECTION SITE HAEMATOMA 13
991 INJECTION SITE URTICARIA 13
992 LIGAMENT SPRAIN 13
993 LOWER LIMB FRACTURE 13
994 NEPHROPATHY TOXIC 13
995 NEPHROSCLEROSIS 13
996 NEPHROTIC SYNDROME 13
997 ONYCHOMADESIS 13
998 PERIPHERAL SENSORY NEUROPATHY 13
999 POSTOPERATIVE WOUND INFECTION 13